ZymoGenetics Licenses Non-Core Assets to Seattle Life Sciences
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 6 (Table of Contents)
Published: 8 Jun-2009
DOI: 10.3833/pdr.v2009.i6.1116 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
ZymoGenetics Inc announced the licensing of rights to eight early stage product candidates to Seattle Life Sciences...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS